Westfield Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,143,835
| Closed | -$142M | – | 265 |
|
|
2018
Q4 | $142M | Buy |
1,143,835
+31,100
| +3% | +$3.86M | 1.21% | 17 |
|
|
2018
Q3 | $187M | Buy |
1,112,735
+228,774
| +26% | +$38.5M | 1.31% | 15 |
|
|
2018
Q2 | $152M | Sell |
883,961
-319,444
| -27% | -$55M | 1.14% | 17 |
|
|
2018
Q1 | $182M | Sell |
1,203,405
-27,167
| -2% | -$4.1M | 1.4% | 8 |
|
|
2017
Q4 | $166M | Sell |
1,230,572
-207,909
| -14% | -$28M | 1.27% | 11 |
|
|
2017
Q3 | $210M | Buy |
1,438,481
+115,217
| +9% | +$16.9M | 1.62% | 5 |
|
|
2017
Q2 | $206M | Sell |
1,323,264
-53,950
| -4% | -$8.39M | 1.75% | 3 |
|
|
2017
Q1 | $200M | Buy |
1,377,214
+117,825
| +9% | +$17.1M | 1.72% | 3 |
|
|
2016
Q4 | $137M | Sell |
1,259,389
-378,548
| -23% | -$41.3M | 1.2% | 15 |
|
|
2016
Q3 | $199M | Sell |
1,637,937
-146,825
| -8% | -$17.8M | 1.61% | 4 |
|
|
2016
Q2 | $252M | Sell |
1,784,762
-254,527
| -12% | -$36M | 2.08% | 2 |
|
|
2016
Q1 | $266M | Sell |
2,039,289
-447,999
| -18% | -$58.5M | 2.03% | 2 |
|
|
2015
Q4 | $350M | Buy |
2,487,288
+188,562
| +8% | +$26.5M | 2.35% | 2 |
|
|
2015
Q3 | $305M | Sell |
2,298,726
-62,732
| -3% | -$8.33M | 2.16% | 4 |
|
|
2015
Q2 | $416M | Buy |
2,361,458
+29,081
| +1% | +$5.12M | 2.54% | 2 |
|
|
2015
Q1 | $403M | Buy |
2,332,377
+399,081
| +21% | +$69M | 2.32% | 2 |
|
|
2014
Q4 | $317M | Sell |
1,933,296
-63,063
| -3% | -$10.3M | 1.86% | 4 |
|
|
2014
Q3 | $321M | Buy |
1,996,359
+101,638
| +5% | +$16.3M | 1.96% | 4 |
|
|
2014
Q2 | $279M | Buy |
1,894,721
+384,791
| +25% | +$56.6M | 1.66% | 5 |
|
|
2014
Q1 | $209M | Buy |
1,509,930
+1,271,735
| +534% | +$176M | 1.25% | 8 |
|
|
2013
Q4 | $30.1M | Buy |
+238,195
| New | +$30.1M | 0.18% | 163 |
|